Patients who suffer from a serious medical condition must take a blood thinner or anticlotting agent to prevent the formation of blood clots that can be deadly. Patients who suffer from deep vein thrombosis (DVT) and various other conditions need to take these medications to prevent potentially deadly medical conditions…
Articles Posted in Pradaxa
A Look at Atrial Fibrillation Treatment Options, Including Pradaxa
Atrial Fibrillation (Afib) is a serious medical condition that affects about one in ten Americans over the age of 65. If someone suffers from atrial fibrillation, which is defined as an irregular heartbeat not associated with a heart valve defect, they will experience what doctors call “bouts” of the condition.…
FDA to Look at Animated Characters in Drug Ads
Many people have seen the recent advertising campaign for Xifaxan, which features what can only be described as an anthropomorphic intestine with a happy face as part of their new commercials. This is similar to Lunesta using a magical butterfly. Now the makers of Pradaxa using animated red goldfish to…
New Reversal Agent for Pradaxa Works on Brain Hemorrhage
A recent article from Tech Times discusses the effects of a new reversal agent for the drug Pradaxa on patients suffering from a brain hemorrhage. It is important to note these are brain hemorrhages caused by the drug Pradaxa, which is a relatively new type of anticoagulant medication. When patients…
FDA Approves Pradaxa for Hip Replacement Patients
Pradaxa is a medication used to reduce the risk of serious clotting disorder in patients who suffer from a potentially serious medical condition known as atrial fibrillation (Afib). Afib patients are at higher risk for forming large blood clots deep within the veins on their legs and other extremities. These…
Watchdog Claims FDA “lax” When Reviewing Blood Thinner Pradaxa
According to a recent news article from the Washington Post, a federal watch group reports the United States Food and Drug Administration (FDA) exercised “lax” judgment and made “questionable” decisions to be accommodating to the pharmaceutical maker Boehringer Ingelheim when reviewing its application for the anticlotting medication known as Pradaxa.…
FDA Approves Antidote for Pradaxa
Pradaxa, like Xarelto and Eliquis have taken the blood thinner/anticoagulant market by storm in recent years as an alternative to the tried and true blood thinner Warfarin (Coumadin). These drugs were designed to treat patients with an irregular heartbeat condition known as atrial fibrillation (Afib). Afib patients are at a…